A late-stage melanoma vaccine report that was posted online and quickly pulled is driving a violent repricing in Moderna (NASDAQ:MRNA | MRNA Price Prediction) shares, even though its findings looked favorable on…
Pfizer's 5.7% dividend yield towers over Merck's, yet that gap may signal something retirees cannot afford to ignore. Before you chase the bigger payout, the coverage numbers behind each dividend tell a…
Moderna‘s (NASDAQ:MRNA | MRNA Price Prediction) push into cancer treatment is drawing heavy buying as a closely followed melanoma presentation approaches. Shares of Moderna are up 7% to $241.89 during the trading…
Soda, toothpaste, phone service, electricity, and prescription drugs all share one trait: people keep buying them when the economy turns ugly. Five companies built their businesses around that reality, and the way…
Eli Lilly just crushed earnings again and sits within striking distance of its all-time high, but a looming price war with Novo Nordisk and a dangerously concentrated revenue base raise real questions…
Pfizer's 5.8% yield looks tempting until you check what the dividend is actually costing the company relative to its cash generation. The math behind that payout is more uncomfortable than the headline…
A yield above 6% looks like a retirement lifeline until the math behind it starts to crack. Five familiar dividend names are flashing the kind of payout warnings that show up quietly…
Most retirees chase yield and end up with dividends that vanish the moment the economy wobbles. These five stocks solve that problem by pairing high payouts with the kind of coverage ratios…
Bristol Myers Squibb has raised its dividend for 17 straight years, but a looming patent cliff and $43 billion in debt put the pace of future increases on a collision course with…
Vaccine stocks are under heavy pressure, and the smallest name in the group is taking the heaviest losses. Novavax (NASDAQ:NVAX) stock is down 12% to $11.23 in afternoon trading, leading the slide…
Profit taking is hitting one of biotech’s hottest trades, and the selling is landing heaviest on the stock that ran the furthest. Moderna (NASDAQ:MRNA | MRNA Price Prediction) stock is down 10%…
Healthcare is drawing fresh buying as money moves away from the market’s popular technology trade, and one messenger RNA (mRNA) name is pulling well ahead of the pack. Moderna (NASDAQ:MRNA | MRNA…
Most of Altria’s (NYSE: MO | MO Price Prediction) revenue comes from cigarettes. It owns the world’s most visible cigarette brand. That is, Marlboro, which is a huge part of its revenue.…
A retiree living off a portfolio needs income that keeps coming. The First Trust Morningstar Dividend Leaders Index Fund (NYSEARCA:FDL) has paid distributions four times a year since 2006. FDL tracks Morningstar’s…
The capital required to collect over $108,000 a year in dividends without selling a share swings by more than $2 million depending on one decision you make before buying anything.
